KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Sales: 2018-2025

Historic Return on Sales for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -0.44%.

  • Guardant Health's Return on Sales rose 30.00% to -0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.44%, marking a year-over-year increase of 30.00%. This contributed to the annual value of -0.59% for FY2024, which is 26.00% up from last year.
  • Guardant Health's Return on Sales amounted to -0.44% in Q3 2025, which was up 11.50% from -0.50% recorded in Q2 2025.
  • Guardant Health's Return on Sales' 5-year high stood at -0.44% during Q3 2025, with a 5-year trough of -1.46% in Q4 2022.
  • For the 3-year period, Guardant Health's Return on Sales averaged around -0.76%, with its median value being -0.76% (2024).
  • In the last 5 years, Guardant Health's Return on Sales plummeted by 76bps in 2021 and then soared by 62bps in 2024.
  • Guardant Health's Return on Sales (Quarterly) stood at -1.03% in 2021, then plummeted by 43bps to -1.46% in 2022, then soared by 61bps to -0.85% in 2023, then rose by 26bps to -0.59% in 2024, then increased by 30bps to -0.44% in 2025.
  • Its Return on Sales was -0.44% in Q3 2025, compared to -0.50% in Q2 2025 and -0.54% in Q1 2025.